Web-Kevin_Lalande-8844-Edit- (Zoom)

Kevin M. Lalande Managing Director

Prior to founding Santé Ventures, Kevin spent seven years with Austin Ventures, a prominent venture firm with $3.9 billion under management. Before joining Austin Ventures, he was a management consultant with McKinsey & Company. Previously, Kevin co-founded and sold three successful start-up companies: NetProfit, sold to a privately held advertising agency in 1996; Serus, sold to Netopia (Nasdaq: NTPA) in 1998; and TimeMarker, sold to PrimeHoldings (OTCBB: PRIM) in 2001. Kevin received an MBA with highest distinction (Baker Scholar) from the Harvard Business School, a Graduate Certificate in Artificial Intelligence from Stanford University, and holds a BS in Electrical and Computer Engineering.

Why Venture Capital Doesn't Scale
News
July 10, 2019 Geneos Therapeutics Announces First Patient Dosed with its DNA-based, Neoantigen-Targeting Personalized Vaccine Technology
Read More
June 26, 2019 Remedy Raises $10 Million to Bring Quality Care Closer to Patients
Read More